Imagine Eyes Lands CE Mark for Its Retinal Camera

Ophthalmology devices maker Imagine Eyes’ imaging system receives CE Mark approval in European Union for clinical use. Orsay, France-based Imagine Eyes landed CE Mark approval to market its rtx1 retinal camera, a device designed to image the retina at the cellular scale, which help clinicians observe the micro vascular structures that are frequently affected by vision-degrading diseases. The newly approved rtx1 retinal camera, which is focused at the retina's cone photoreceptor layer to avoid image blurring, is the 1st adaptive optics platform system approved for clinical use, the company said. "The technology is protected by 4 proprietary patents," director of global communications Mark Zacharria said in prepared remarks. "These cover different aspects of the device's optical architecture that enable its superior image quality."